William Love
Oprichter bij DESTINY PHARMA PLC
Vermogen: 1 M $ op 30-04-2024
Actieve functies van William Love
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
DESTINY PHARMA PLC | Directeur/Bestuurslid | 01-05-2017 | - |
Hoofd Techniek/Wetenschap/O&O | 13-04-2017 | - | |
Oprichter | 04-03-1996 | - | |
Algemeen Directeur | 04-03-1996 | 20-01-2017 |
Loopbaan van William Love
Eerdere bekende functies van William Love
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Verenigd Koninkrijk | 2 |
Frankrijk | 2 |
Operationeel
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
DESTINY PHARMA PLC | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Beam Alliance
Beam Alliance Pharmaceuticals: MajorHealth Technology Beam Alliance is a French company that collaborates with the existing community of stakeholders to foster tangible policies and incentives for the discovery and development of novel antibacterial therapies and diagnostics. The private company is based in Paris, France. The company is aware of the problem arising from the lack of differentiation between different antimicrobials and has set up a dedicated scientific team, namely the Beam Task Force - E (BTF-E), to tackle the issue and propose solutions for better evaluating antimicrobial efficacy within a regulatory context. The company was founded by Florence Séjourné. | Health Technology |
- Beurs
- Insiders
- William Love
- Ervaring